RANI
Price
$0.42
Change
-$0.00 (-0.00%)
Updated
Jul 21, 04:36 PM (EDT)
Capitalization
18.12M
17 days until earnings call
VYGR
Price
$3.32
Change
+$0.08 (+2.47%)
Updated
Jul 21, 10:57 AM (EDT)
Capitalization
179.29M
10 days until earnings call
Interact to see
Advertisement

RANI vs VYGR

Header iconRANI vs VYGR Comparison
Open Charts RANI vs VYGRBanner chart's image
Rani Therapeutics Holdings
Price$0.42
Change-$0.00 (-0.00%)
Volume$729
Capitalization18.12M
Voyager Therapeutics
Price$3.32
Change+$0.08 (+2.47%)
Volume$1.18K
Capitalization179.29M
RANI vs VYGR Comparison Chart in %
Loading...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RANI vs. VYGR commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RANI is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (RANI: $0.42 vs. VYGR: $3.24)
Brand notoriety: RANI and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RANI: 48% vs. VYGR: 71%
Market capitalization -- RANI: $18.12M vs. VYGR: $179.29M
RANI [@Biotechnology] is valued at $18.12M. VYGR’s [@Biotechnology] market capitalization is $179.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RANI’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • RANI’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RANI’s TA Score shows that 2 TA indicator(s) are bullish while VYGR’s TA Score has 6 bullish TA indicator(s).

  • RANI’s TA Score: 2 bullish, 7 bearish.
  • VYGR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than RANI.

Price Growth

RANI (@Biotechnology) experienced а -35.47% price change this week, while VYGR (@Biotechnology) price change was -7.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.61%.

Reported Earning Dates

RANI is expected to report earnings on Aug 07, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($179M) has a higher market cap than RANI($18.1M). VYGR YTD gains are higher at: -42.857 vs. RANI (-69.664). RANI has higher annual earnings (EBITDA): -48.83M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. RANI (15.9M). RANI has less debt than VYGR: RANI (25.7M) vs VYGR (42M). VYGR has higher revenues than RANI: VYGR (67M) vs RANI (1.2M).
RANIVYGRRANI / VYGR
Capitalization18.1M179M10%
EBITDA-48.83M-97.25M50%
Gain YTD-69.664-42.857163%
P/E RatioN/A6.32-
Revenue1.2M67M2%
Total Cash15.9M236M7%
Total Debt25.7M42M61%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RANIVYGR
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOBQ1.540.10
+7.12%
Mobiquity Technologies, Inc.
KBLB0.08N/A
+2.08%
Kraig Biocraft Laboratories, Inc.
NURAF36.700.55
+1.52%
Nomura Research Institute Ltd.
FLMNF64.00N/A
N/A
Fielmann Group AG
CHTH2.90N/A
N/A
CNL Healthcare Pptys Inc.

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-0.31%
XENE - RANI
36%
Loosely correlated
N/A
VNDA - RANI
33%
Loosely correlated
-1.65%
ADVM - RANI
33%
Loosely correlated
+0.36%
VYGR - RANI
32%
Poorly correlated
+0.62%
PGEN - RANI
30%
Poorly correlated
-3.30%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+0.62%
RGNX - VYGR
51%
Loosely correlated
-6.10%
KYMR - VYGR
50%
Loosely correlated
-0.37%
TRDA - VYGR
47%
Loosely correlated
-1.88%
XNCR - VYGR
47%
Loosely correlated
-1.10%
IMNM - VYGR
47%
Loosely correlated
+1.24%
More